News Room

  • Co-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of Health

    Co-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of Health October 16, 2017 07:30 AM Eastern Daylight Time SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today upcoming meetings with the Ministry of Public Health […]
  • Co-Diagnostics, Inc. to Present at Robins Equity Research Roundup 2017

    Co-Diagnostics, Inc. to Present at Robins Equity Research Roundup 2017 September 25, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that it will be presenting at the Third Annual Robins […]
  • Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017

    Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017 September 07, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that CEO Dwight Egan will represent Co-Diagnostics as a Presenting Company at […]
  • Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs

    Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs September 05, 2017 09:31 AM Eastern Daylight Time SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, and MEDCIS Pathlabs India Pvt. Ltd., have agreed to the terms of a purchase […]
  • Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin

    Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin Sales expected upon successful performance evaluation and validation August 24, 2017 07:30 AM Eastern Daylight Time SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that they have strengthened […]
  • Co-Diagnostics, Inc. CEO to Present at 2017 SALSS

    Co-Diagnostics, Inc. CEO to Present at 2017 SALSS August 22, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that CEO Dwight Egan will be a presenter at the 2017 Swedish-American […]
  • Co-Diagnostics, Inc. to Undergo ISO 13485:2016 Audit

    Co-Diagnostics, Inc. to Undergo ISO 13485:2016 Audit Audit to prepare for eventual sales into the US market August 10, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, will be undergoing a Stage […]
  • Co-Diagnostics, Inc. to Attend AACC 2017

    Co-Diagnostics, Inc. to Attend AACC 2017 August 02, 2017 12:12 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, will be sending Company representatives on August 2-3, 2017, to attend the 69th AACC Annual Scientific Meeting […]
  • Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test

    Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test   SALT LAKE CITY, July 27, 2017 (GLOBE NEWSWIRE) — Co-Diagnostics, Inc. (NASDAQ:CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, has completed principle design and verification of its Zika test built on the Company’s CoPrimer™ technology. The […]
  • Co-Diagnostics, Inc. Announces Joint Venture in India

    Co-Diagnostics, Inc. Announces Joint Venture in India   SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced today the recent incorporation of CoSara Diagnostics, Pvt., Ltd., a Joint Venture for manufacturing with Synbiotics Limited. Synbiotics is […]
  • Co-Diagnostics, Inc. to Use IPO Proceeds to Expand Operations

    Co-Diagnostics, Inc. to Use IPO Proceeds to Expand Operations SALT LAKE CITY, UTAH (PRWEB) JULY 17, 2017 Salt Lake City, UT – July 17, 2017 – Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and intends both to manufacture and sell reagents used for diagnostic tests, has completed its […]
  • Co-Diagnostics, Inc. Announces Pricing of IPO

    Co-Diagnostics, Inc. Announces Pricing of IPO Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests, announced today that its initial public offering of 1,178,532 shares of common stock has been priced at $6.00 per share. Total gross proceeds […]
  • Eureka Labs hosts Co-Diagnostics and touts partnership

    Following a visit to Eureka Medical Laboratories (EML) in Georgetown, Guyana, EML was featured in an article in the Guyana Times. In speaking of the event, Co-Diagnostics president and CEO Dwight Egan said: “We plan to make available a large menu of tests over the coming year that will enable the citizens of Guyana to […]
  • Co-Diagnostics mention in local press

    Co-Diagnostics received a mention from a local news outlet for being on the front lines of the war on Zika. The full text can be found by clicking the headline here: ‘It’s a full-frontal attack’: Utah companies, universities continue Zika research    
  • Co-Diagnostics Presents Technology to Woodlands Hospital, Guyana

    Co-Diagnostics CEO Dwight Egan is currently visiting the countries of Guyana and Trinidad and Tobago, where he has been invited to introduce our revolutionary testing solutions to select hospitals and laboratories in those regions. On October 24, 2016, Mr. Egan and two members of our science team presented Co-Diagnostics’ Zika Virus Rapid Test™  to staff and press […]